Trial Data Shows Benefit of Bylvay Dose Escalation in Progressive Familial Intrahepatic Cholestasis
According to a story from Globe Newswire, the rare disease company Albireo Pharma, Inc. has recently announced the release of new data from its phase 3 trials. These trials were…